The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.
- First select the CSR Section, then a Table/Figure from that section.
- Use the Submit button to view the table or figure. You will have options to download a printer-friendly version or the data table (CSV) as well.
To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 85 KB) and Technical Notes (PDF, 282 KB) pages.
Download and Print: Download Printer-friendly PDF Download data
Table 28.14
Age at Death | Primary Site | Rate | Number of Deaths |
---|---|---|---|
Age <1 | All Sites | 1.7 | 354 |
Leukemia | 0.6 | 131 | |
Acute Lymphocytic Leukemia | 0.2 | 46 | |
Brain and ONSd | 0.3 | 67 | |
Other Endocrine | 0.2 | 33 | |
Liver & IBDd | 0.1 | 22 | |
Soft Tissue | 0.1 | 16 | |
Age 1 | All Sites | 1.9 | 381 |
Leukemia | 0.8 | 154 | |
Acute Lymphocytic Leukemia | 0.2 | 44 | |
Brain and ONSd | 0.5 | 96 | |
Other Endocrine | 0.2 | 46 | |
Liver & IBDd | 0.1 | 17 | |
Soft Tissue | 0.1 | 16 | |
Age 2 | All Sites | 2.3 | 461 |
Leukemia | 0.8 | 168 | |
Acute Lymphocytic Leukemia | 0.3 | 54 | |
Brain and ONSd | 0.5 | 109 | |
Other Endocrine | 0.4 | 85 | |
Liver & IBDd | 0.1 | 30 | |
Soft Tissue | 0.1 | 23 | |
Age 3 | All Sites | 2.5 | 505 |
Brain and ONSd | 0.7 | 146 | |
Leukemia | 0.7 | 146 | |
Acute Lymphocytic Leukemia | 0.2 | 48 | |
Other Endocrine | 0.5 | 104 | |
Soft Tissue | 0.2 | 33 | |
Liver & IBDd | 0.1 | 21 | |
Age 4 | All Sites | 2.4 | 484 |
Brain and ONSd | 0.8 | 163 | |
Leukemia | 0.6 | 115 | |
Acute Lymphocytic Leukemia | 0.2 | 49 | |
Other Endocrine | 0.4 | 87 | |
Soft Tissue | 0.1 | 27 | |
Kidney and Renal Pelvis | 0.1 | 22 | |
Age 5 | All Sites | 2.4 | 484 |
Brain and ONSd | 1.0 | 192 | |
Leukemia | 0.5 | 108 | |
Acute Lymphocytic Leukemia | 0.3 | 57 | |
Other Endocrine | 0.4 | 71 | |
Kidney and Renal Pelvis | 0.1 | 30 | |
Soft Tissue | 0.1 | 26 | |
Age 6 | All Sites | 2.3 | 463 |
Brain and ONSd | 0.9 | 171 | |
Leukemia | 0.5 | 102 | |
Acute Lymphocytic Leukemia | 0.3 | 51 | |
Other Endocrine | 0.4 | 75 | |
Kidney and Renal Pelvis | 0.1 | 30 | |
Soft Tissue | 0.1 | 28 | |
Age 7 | All Sites | 2.4 | 479 |
Brain and ONSd | 1.0 | 192 | |
Leukemia | 0.6 | 111 | |
Acute Lymphocytic Leukemia | 0.3 | 67 | |
Other Endocrine | 0.3 | 63 | |
Soft Tissue | 0.2 | 37 | |
Bones and Joints | 0.1 | 19 | |
Age 8 | All Sites | 2.3 | 447 |
Brain and ONSd | 0.8 | 163 | |
Leukemia | 0.6 | 125 | |
Acute Lymphocytic Leukemia | 0.4 | 73 | |
Other Endocrine | 0.3 | 50 | |
Soft Tissue | 0.2 | 33 | |
Kidney and Renal Pelvis | - | - | |
Age 9 | All Sites | 2.2 | 439 |
Brain and ONSd | 0.8 | 164 | |
Leukemia | 0.6 | 125 | |
Acute Lymphocytic Leukemia | 0.3 | 69 | |
Bones and Joints | 0.2 | 33 | |
Other Endocrine | 0.2 | 33 | |
Soft Tissue | 0.1 | 28 | |
Age 10 | All Sites | 2.0 | 406 |
Leukemia | 0.7 | 152 | |
Acute Lymphocytic Leukemia | 0.3 | 70 | |
Brain and ONSd | 0.6 | 124 | |
Other Endocrine | 0.2 | 37 | |
Bones and Joints | 0.2 | 32 | |
Soft Tissue | 0.1 | 26 | |
Age 11 | All Sites | 2.2 | 451 |
Leukemia | 0.7 | 147 | |
Acute Lymphocytic Leukemia | 0.4 | 74 | |
Brain and ONSd | 0.7 | 140 | |
Bones and Joints | 0.2 | 39 | |
Other Endocrine | 0.2 | 34 | |
Non-Hodgkin Lymphoma | 0.1 | 21 | |
Age 12 | All Sites | 2.1 | 445 |
Leukemia | 0.6 | 135 | |
Acute Lymphocytic Leukemia | 0.3 | 61 | |
Brain and ONSd | 0.6 | 127 | |
Bones and Joints | 0.3 | 56 | |
Soft Tissue | 0.2 | 40 | |
Non-Hodgkin Lymphoma | 0.1 | 19 | |
Age 13 | All Sites | 2.3 | 491 |
Leukemia | 0.7 | 153 | |
Acute Lymphocytic Leukemia | 0.3 | 72 | |
Brain and ONSd | 0.6 | 135 | |
Bones and Joints | 0.2 | 47 | |
Soft Tissue | 0.2 | 34 | |
Non-Hodgkin Lymphoma | 0.1 | 29 | |
Age 14 | All Sites | 2.2 | 463 |
Leukemia | 0.8 | 161 | |
Acute Lymphocytic Leukemia | 0.3 | 65 | |
Brain and ONSd | 0.5 | 100 | |
Bones and Joints | 0.3 | 64 | |
Soft Tissue | 0.2 | 42 | |
Non-Hodgkin Lymphoma | 0.1 | 20 | |
Age 15 | All Sites | 2.6 | 563 |
Leukemia | 0.9 | 198 | |
Acute Lymphocytic Leukemia | 0.3 | 73 | |
Brain and ONSd | 0.5 | 103 | |
Bones and Joints | 0.3 | 72 | |
Soft Tissue | 0.2 | 49 | |
Non-Hodgkin Lymphoma | 0.2 | 36 | |
Age 16 | All Sites | 2.9 | 630 |
Leukemia | 0.8 | 179 | |
Acute Lymphocytic Leukemia | 0.3 | 69 | |
Brain and ONSd | 0.5 | 107 | |
Bones and Joints | 0.5 | 104 | |
Soft Tissue | 0.3 | 63 | |
Non-Hodgkin Lymphoma | 0.2 | 42 | |
Age 17 | All Sites | 2.7 | 602 |
Leukemia | 0.8 | 174 | |
Acute Lymphocytic Leukemia | 0.4 | 78 | |
Bones and Joints | 0.5 | 115 | |
Brain and ONSd | 0.4 | 99 | |
Soft Tissue | 0.2 | 55 | |
Non-Hodgkin Lymphoma | 0.1 | 31 | |
Age 18 | All Sites | 3.1 | 686 |
Leukemia | 0.9 | 204 | |
Acute Lymphocytic Leukemia | 0.4 | 85 | |
Bones and Joints | 0.6 | 129 | |
Brain and ONSd | 0.4 | 80 | |
Soft Tissue | 0.3 | 64 | |
Non-Hodgkin Lymphoma | 0.2 | 48 | |
Age 19 | All Sites | 3.6 | 797 |
Leukemia | 0.8 | 185 | |
Acute Lymphocytic Leukemia | 0.4 | 78 | |
Brain and ONSd | 0.5 | 120 | |
Bones and Joints | 0.5 | 119 | |
Soft Tissue | 0.4 | 91 | |
Non-Hodgkin Lymphoma | 0.3 | 66 |
Footnotes:
a Rates are per 100,000 per year. Deaths are for the entire United States over the time period 2006-2010.
b Top 5 cancer sites were determined based on the 2006-2010 age-specific rate.
c US Mortality Files, National Center for Health Statistics, Centers for Disease Control and Prevention.
d ONS = Other Nervous System. IBD = Intrahepatic Bile Duct.
e The rates for sex-specific cancer sites are calculated using the population for both sexes combined.
- Statistic not shown. Rate based on less than 16 cases for the time interval.
Page Navigation: << Previous Next >>
The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.